These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7931438)

  • 1. Guillain-Barré syndrome: the evolution of therapy.
    Cornblath DR; Hughes RA
    J Neurol; 1994 May; 241(6):404-5. PubMed ID: 7931438
    [No Abstract]   [Full Text] [Related]  

  • 2. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
    van der Meché FG
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
    [No Abstract]   [Full Text] [Related]  

  • 3. Rational therapy of Guillain-Barré syndrome.
    Raphael JC; Chevret S
    Lancet; 1998 Mar; 351(9104):753. PubMed ID: 9504542
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    Ng KK; Howard RS; Hirsch NP; Miller DH
    Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous immunoglobulins in Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Ann Fr Anesth Reanim; 1992; 11(1):115. PubMed ID: 1443803
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    van der Meché FG; van Doorn PA; Schmitz PI
    Neurology; 1993 Dec; 43(12):2730; author reply 2730-1. PubMed ID: 8255496
    [No Abstract]   [Full Text] [Related]  

  • 7. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP; van der Meché FG; Schmitz PI
    Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous IgG in Guillain-Barré syndrome.
    Hughes RA
    BMJ; 1996 Aug; 313(7054):376-7. PubMed ID: 8761208
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute Guillain-Barré syndrome?
    Weinstein R
    J Clin Apher; 1995; 10(3):150-7. PubMed ID: 8582898
    [No Abstract]   [Full Text] [Related]  

  • 12. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome.
    Rees JH
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148-9. PubMed ID: 9489520
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF; Rosenow F; van der Ven C; Borberg H; Pawlik G
    J Neurol Sci; 1996 May; 137(2):145-9. PubMed ID: 8782169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF; Rosenow F; van der Ven C; Borberg H; Pawlik G
    Ther Apher; 1997 Feb; 1(1):55-7. PubMed ID: 10225782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.
    Hughes RA; Hadden RD; Rees JH; Swan AV
    Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing views of Guillain-Barré syndrome.
    Asbury AK; McKhann GM
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.